VEGF‐TRAP<sub>R1R2</sub> suppresses choroidal neovascularization and VEGF‐induced breakdown of the blood–retinal barrier
Yoshitsugu Saishin(Johns Hopkins University), Peter A. Campochiaro(Johns Hopkins University), Raquel Lima e Silva(Johns Hopkins Medicine), Stanley J. Wiegand(Regeneron (United States)), Kyoichi Takahashi(Johns Hopkins University), Yumiko Saishin(Johns Hopkins University), John S. Rudge(MedStar Washington Hospital Center), Donna Hylton(Regeneron (United States))
Cited by 239
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k
Seven new loci associated with age-related macular degeneration
|Nature Genetics|2013|802
Angiopoietin-1 Is an Antipermeability and Anti-Inflammatory Agent In Vitro and Targets Cell Junctions
|Circulation Research|2000|499